Literature DB >> 28683447

Swiss Practice Recommendations for the Management of Hidradenitis Suppurativa/Acne Inversa.

Robert E Hunger1, Emanuel Laffitte, Severin Läuchli, Carlo Mainetti, Michael Mühlstädt, Peter Schiller, Anne-Karine Lapointe, Pascale Meschberger, Alexander A Navarini.   

Abstract

Hidradenitis suppurativa (HS) is a painful, inflammatory, debilitating skin disease with a chronic intermittent course. The central pathogenetic event seems to be the occlusion of the hair follicle. HS has a 1-year prevalence of about 1%. It typically presents after puberty with painful, deep-seated, inflamed lesions in the apocrine gland-bearing areas of the body: most commonly the axillae, inguinal, and anogenital regions. HS has a high negative impact on patients' quality of life even in patients with only limited disease burden, and the diagnosis of HS is often made with a long diagnostic delay. In this practical short version we present diagnostic and therapeutic recommendations which are based on a systematic literature search as well as an informal expert consensus of Swiss dermatologists and dermatosurgeons.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Acne inversa; Diagnosis; Hidradenitis suppurativa; Pathogenesis; Recommendations; Treatment

Mesh:

Year:  2017        PMID: 28683447     DOI: 10.1159/000477459

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  10 in total

Review 1.  Medical Management of Hidradenitis Suppurativa with Non-Biologic Therapy: What's New?

Authors:  Soha Ghanian; Mika Yamanaka-Takaichi; Haley B Naik; Afsaneh Alavi
Journal:  Am J Clin Dermatol       Date:  2022-01-06       Impact factor: 6.233

2.  Identification of Hidradenitis Suppurativa-Related mRNA Expression Patterns Through Analysis of Gene Expression Omnibus.

Authors:  Yan Teng; Xiaohua Tao; Wei Lu; Youming Huang; Danfeng Xu; Meng Li; Yibin Fan
Journal:  Dose Response       Date:  2020-07-24       Impact factor: 2.658

Review 3.  Hidradenitis suppurativa.

Authors:  Robert Sabat; Gregor B E Jemec; Łukasz Matusiak; Alexa B Kimball; Errol Prens; Kerstin Wolk
Journal:  Nat Rev Dis Primers       Date:  2020-03-12       Impact factor: 52.329

Review 4.  Non-contrast-enhanced 3-Tesla Magnetic Resonance Imaging Using Surface-coil and Sonography for Assessment of Hidradenitis Suppurativa Lesions.

Authors:  Fatemeh Jabbary Lak; Mona Mazinani; Johannes T Heverhagen; Robert E Hunger; Keivan Daneshvar; S Morteza Seyed Jafari
Journal:  Acta Derm Venereol       Date:  2020-11-12       Impact factor: 3.875

5.  Clinical and Ultrasonographic Profile of Adalimumab-treated Hidradenitis Suppurativa Patients: A Real-life Monocentric Experience.

Authors:  Andrea Chiricozzi; Giulia Giovanardi; Simone Garcovich; Dalma Malvaso; Giacomo Caldarola; Barbara Fossati; Cristina Guerriero; Clara De Simone; Ketty Peris
Journal:  Acta Derm Venereol       Date:  2020-06-11       Impact factor: 3.875

6.  Clinico-Epidemiological Characteristics of Hidradenitis Suppurativa: A Retrospective Cohort Study from a Tertiary Care Centre in Northern India.

Authors:  Divya Kamat; Sunil Gaba; Muthu S Kumaran
Journal:  Indian Dermatol Online J       Date:  2021-06-20

Review 7.  Efficacy and Toxicity of Classical Immunosuppressants, Retinoids and Biologics in Hidradenitis Suppurativa.

Authors:  Kinnor Das; Steven Daveluy; George Kroumpouzos; Komal Agarwal; Indrashis Podder; Katherine Farnbach; Alex G Ortega-Loayza; Jacek C Szepietowski; Stephan Grabbe; Mohamad Goldust
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

Review 8.  Pain management in hidradenitis suppurativa and a proposed treatment algorithm.

Authors:  Kevin T Savage; Vinita Singh; Zarine S Patel; Christine A Yannuzzi; Anne Marie McKenzie-Brown; Michelle A Lowes; Lauren A V Orenstein
Journal:  J Am Acad Dermatol       Date:  2020-09-17       Impact factor: 15.487

Review 9.  Hidradenitis Suppurativa: Current Understanding of Pathogenic Mechanisms and Suggestion for Treatment Algorithm.

Authors:  S Morteza Seyed Jafari; Robert E Hunger; Christoph Schlapbach
Journal:  Front Med (Lausanne)       Date:  2020-03-04

10.  Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: 12-week interim analysis of post-marketing surveillance in Japan.

Authors:  Nobukazu Hayashi; Koremasa Hayama; Kenzo Takahashi; Ichiro Kurokawa; Masateru Okazaki; Tomoko Kashiwagi; Eri Iwashita; Tadashi Terui
Journal:  J Dermatol       Date:  2022-01-17       Impact factor: 3.468

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.